Treatment with vitamin D can inhibit bone resorption in mice with thyrotoxicosis and significantly improve the BMD and trabecular bone architecture of the lumbar vertebrae and femur, which may be achieved by the OPG/RANKL and Wnt/β-catenin signaling pathways. This evidence concerns the gene TNFRSF11B and thyrotoxicosis.